Susquehanna Fundamental Investments’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,000
Closed -$509K 957
2025
Q1
$509K Hold
4,000
0.01% 835
2024
Q4
$576K Buy
+4,000
New +$574K 0.01% 830
2023
Q1
Sell
-30,399
Closed -$5.15M 1074
2022
Q4
$5.15M Sell
30,399
-31,822
-51% -$5.77M 0.09% 288
2022
Q3
$11.6M Buy
+62,221
New +$13.1M 0.2% 139
2022
Q1
$10.7M Buy
56,803
+52,791
+1,316% +$10M 0.21% 121
2021
Q4
$1.06M Hold
4,012
0.03% 630
2021
Q3
$1.16M Sell
4,012
-11,900
-75% -$3.05M 0.02% 808
2021
Q2
$3.18M Sell
15,912
-24,688
-61% -$4.79M 0.06% 448
2021
Q1
$7.89M Hold
40,600
0.14% 202
2020
Q4
$7.78M Hold
40,600
0.14% 195
2020
Q3
$5.99M Hold
40,600
0.18% 143
2020
Q2
$5.02M Buy
+40,600
New +$4.78M 0.24% 94

Other funds holding RGEN

Susquehanna Fundamental Investments's RGEN Position: Q2 2025 in Review

Susquehanna Fundamental Investments sold out of Repligen (RGEN) in Q2 2025, closing a stake of 4,000 shares — an estimated $509K sold.

Susquehanna Fundamental Investments first reported a position in RGEN in Q2 2020 and held it in 12 quarters. The position peaked at $11.6M in Q3 2022. 444 funds tracked by Wall St. Rank hold RGEN as of Q2 2025.

  • Susquehanna Fundamental Investments reported no remaining Repligen position as of Q2 2025 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 4,000 Repligen shares in Q2 2025, an estimated $509K.
  • Susquehanna Fundamental Investments first reported a position in Repligen in Q2 2020 and held it in 12 quarters.
  • Susquehanna Fundamental Investments's Repligen position peaked at $11.6M in Q3 2022.
  • 444 funds tracked by Wall St. Rank held Repligen as of Q2 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2025, filed 14 Aug 2025.